Vringo, Inc.(AMEX:VRNG) shares increased 1.57% to $3.88. The company, early this month, filed a lawsuit against ZTE Corp.'s U.K. unit for alleged infringement of its patents for handsets, base stations and base station controllers. Representatives of ZTE weren't immediately available for comment.
Will VRNG Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://csrnewsdaily.com/c1/?company=VRNG
GeoGlobal Resources Inc.(AMEX:GGR) stock dropped 9.50% to $0.0724. The company announced that the Sara-1 exploration well has reached a final Total Vertical Depth Subsea of 3,928 meters. Based on the cutting samples and logging performed during the drilling, the Company encountered approximately 98 meters of high quality reservoir sands in the lower Miocene / upper Oligocene which had good porosity and permeability.
How Should Investors Trade GGR After The Recent Momentum, Find Out Here http://csrnewsdaily.com/c1/?company=GGR
Houston American Energy Corporation(AMEX:HUSA) stock declined 2.32% to $0.400 after the company announced that it has closed on its registered direct equity offering of 14.81 million units at $0.675 per unit, with each unit consisting of one of the Company's common shares, one Class A Warrant to purchase one-half share of common stock and one Class B Warrant to purchase one half share of common stock, for gross proceeds of approximately $10.0 million, before deducting placement agent fees and offering expenses.
Get Free Special Trend Analysis On HUSA Here http://csrnewsdaily.com/c1/?company=HUSA
Hemispherx BioPharma, Inc(AMEX:HEB) shares decreased 1.73% to $0.624 in the early hour after the company announced that the U.S. Food and Drug Administration ("FDA") has scheduled for December 20, 2012 a meeting of the Arthritis Advisory Committee ("AAC") to discuss the Ampligen® New Drug Application for Chronic Fatigue Syndrome ("CFS") which is currently under review by the FDA. As previously announced, the Prescription Drug User Fee Act ("PDUFA") review goal for the FDA to complete its review is February 2, 2013.
Get Free Special Trend Analysis On HEB Here http://csrnewsdaily.com/c1/?company=HEB
Walter Investment Management Corp(AMEX:WAC) shares increased 4.22% to $45.40. The company announced the pricing of previously announced registered underwritten public offering of common stock. The Company increased the size of the common stock offering from 4,500,000 shares to 6,000,000 shares. The shares will be sold at a price to the public of $42.00 per share. The Company also announced pricing of previously announced registered underwritten public offering of $265.0 million aggregate principal amount of 4.50% convertible senior subordinated notes due 2019.
Get Free Special Trend Analysis On WAC Here http://csrnewsdaily.com/c1/?company=WAC
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Pacific Dynasty Consultants Inc.
2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062